Marle serves the worldwide orthopaedic industry with specialized manufacturing services to produce hip, knee, shoulder, spine and extremities implants and instruments of the highest quality, within the shortest timeframe. IK Investment has acquired the control of Marle in a secondary LBO from Carlyle.
Wagram Corporate Finance
Advised in the sale of
Marle
to